Bristol-Myers Squibb Q4 2024 Earnings Preview: Strong product sales to continue into 2025
Bristol-Myers Squibb (BMY) to announce Q4 earnings on February 6th. Analysts expect $1.47 EPS on $11.56B revenue.
PayPal Q4: Don't Panic, It's Still An Earnings Beat
Analysis of PayPal Holdings, Inc.'s Q4 performance, including revenue growth, guidance for FY 2025, and stock valuation.
Equinor Unveils $5 Billion Buyback, Trims Renewables Spending As Oil & Gas Output Rises
Equinor (NYSE: EQNR) reports Q4 results with revenue and production decline, but beats EPS estimate. Plans to strengthen cash flow and increase renewable energy capacity.
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion
GSK's Q4 sales hit $10.40 billion, topping estimates. Specialty Medicines grew 14%, while vaccines declined. The company ...
24/7 Wall St. on MSN2d
3 Blue-Chip Dividend Giants Hit the Wall in Q4: Buy Them Now for the Comeback
Investors love dividend stocks, especially the blue-chip variety because they offer a significant income stream and have ...